Cellulora
Cellulora creates a permanent, injectable cellulose hydrogel that can be safely reversed on demand.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Cellulora creates a permanent, injectable cellulose hydrogel that can be safely reversed on demand.
Regenerative MedicinePlastic SurgeryUrology
Technology Platform
A two‑component cellulose‑based hydrogel that thermally gels and chemically cross‑links in situ, providing a permanent, biocompatible filler that can be enzymatically reversed within 24 hours.
Opportunities
Leverage the growing demand for durable, minimally invasive soft‑tissue fillers in both cosmetic and medical markets, and capitalize on the unique reversible property to differentiate from permanent implants.
Risk Factors
Regulatory approval timelines, potential competition from alternative biomaterials, and the need to demonstrate long‑term safety and efficacy of the reversible hydrogel.
Competitive Landscape
Competes with traditional surgical implants and temporary fillers (e.g., hyaluronic acid, calcium hydroxylapatite); differentiation lies in its permanent yet enzymatically reversible design and tunable mechanical properties.